These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2207301)

  • 1. The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humans.
    Evans AM; Nation RL; Sansom LN; Bochner F; Somogyi AA
    Biopharm Drug Dispos; 1990; 11(6):507-18. PubMed ID: 2207301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interindividual variability in the enantiomeric disposition of ibuprofen following the oral administration of the racemic drug to healthy volunteers.
    Avgerinos A; Hutt AJ
    Chirality; 1990; 2(4):249-56. PubMed ID: 2083147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ibuprofen enantiomers after single and repeated doses in man.
    Oliary J; Tod M; Nicolas P; Petitjean O; Caillé G
    Biopharm Drug Dispos; 1992 Jul; 13(5):337-44. PubMed ID: 1498267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective disposition of ibuprofen enantiomers in man.
    Lee EJ; Williams K; Day R; Graham G; Champion D
    Br J Clin Pharmacol; 1985 May; 19(5):669-74. PubMed ID: 4005104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
    Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
    Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and conditions for the requirement of chiral bioanalytical methods in bioequivalence studies.
    Torrado JJ; Blanco M; Farré M; Roset P; García-Arieta A
    Eur J Clin Pharmacol; 2010 Jun; 66(6):599-604. PubMed ID: 20195587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of cimetidine on the pharmacokinetics of R(-)- and S(+)-ibuprofen.
    Evans AM; Nation RL; Sansom LN
    Br J Clin Pharmacol; 1989 Aug; 28(2):143-9. PubMed ID: 2775619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of S(+)- and R(-)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis.
    Geisslinger G; Schuster O; Stock KP; Loew D; Bach GL; Brune K
    Eur J Clin Pharmacol; 1990; 38(5):493-7. PubMed ID: 2379535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of gender and oral contraceptive steroids on the pharmacokinetics of (R)-ibuprofen in humans.
    Knights KM; McLean CF; Tonkin AL; Miners JO
    Br J Clin Pharmacol; 1995 Aug; 40(2):153-6. PubMed ID: 8562298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective systemic disposition of ibuprofen enantiomers in the dog.
    Ahn HY; Amidon GL; Smith DE
    Pharm Res; 1991 Sep; 8(9):1186-90. PubMed ID: 1788165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interaction of ibuprofen enantiomers in rabbits.
    Lin W; Hayakawa T; Yanaguimoto H; Kuzuba M; Obara T; Ding G; Cui F; Inotsume N
    J Pharm Pharmacol; 2004 Mar; 56(3):317-21. PubMed ID: 15025856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselectivity of ibuprofen metabolism and pharmacokinetics following the administration of the racemate to healthy volunteers.
    Tan SC; Patel BK; Jackson SH; Swift CG; Hutt AJ
    Xenobiotica; 2002 Aug; 32(8):683-97. PubMed ID: 12296989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of food or sucralfate on the bioavailability of S(+) and R(-) enantiomers of ibuprofen.
    Levine MA; Walker SE; Paton TW
    J Clin Pharmacol; 1992 Dec; 32(12):1110-4. PubMed ID: 1487549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chiral separation of ibuprofen and chiral pharmacokinetics in healthy Chinese volunteers.
    Zheng C; Hao H; Wang G; Sang G; Sun J; Li P; Li J
    Eur J Drug Metab Pharmacokinet; 2008; 33(1):45-51. PubMed ID: 18543584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates.
    Jamali F; Singh NN; Pasutto FM; Russell AS; Coutts RT
    Pharm Res; 1988 Jan; 5(1):40-3. PubMed ID: 3244607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane production and the plasma unbound concentration of S(+)-ibuprofen.
    Evans AM; Nation RL; Sansom LN; Bochner F; Somogyi AA
    Br J Clin Pharmacol; 1991 Feb; 31(2):131-8. PubMed ID: 1904749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the bioavailability of dexibuprofen administered alone or as part of racemic ibuprofen.
    Gabard B; Nirnberger G; Schiel H; Mascher H; Kikuta C; Mayer JM
    Eur J Clin Pharmacol; 1995; 48(6):505-11. PubMed ID: 8582471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacology of S(+)-ibuprofen and (RS)-ibuprofen.
    Evans AM
    Clin Rheumatol; 2001 Nov; 20 Suppl 1():S9-14. PubMed ID: 11771573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting and postprandial disposition of R(-)- and S(+)-ibuprofen following oral administration of racemic drug in healthy individuals.
    Siemon D; de Vries JX; Stötzer F; Walter-Sack I; Dietl R
    Eur J Med Res; 1997 May; 2(5):215-9. PubMed ID: 9153347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of age on the enantiomeric disposition of ibuprofen in healthy volunteers.
    Tan SC; Patel BK; Jackson SH; Swift CG; Hutt AJ
    Br J Clin Pharmacol; 2003 Jun; 55(6):579-87. PubMed ID: 12814452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.